Abstract Coronavirus disease 2019 (COVID-19) or severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), a novel coronavirus strain disease, has recently emerged in …

Abstract Coronavirus disease 2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recently …

In October 2019, a viral infectious disease appeared in the city of Wuhan in China. A new
betacoronavirus, SARS-CoV-2, has been recognized as the responsible pathogen in this …

In critically ill patients with acute respiratory distress syndrome (ARDS) coronavirus disease
2019 (COVID-19), a high incidence of thromboembolic and hemorrhagic events is reported …

Abstract Coronavirus-19 disease (COVID-19), a zoonosis, was first reported in the city of
Wuhan, province of Hubei, China in December 2019. The disease is caused by the Severe …

The novel coronavirus infection (COVID-19) is caused by the new coronavirus SARS-CoV-2
and is characterized by an exaggerated inflammatory response that can lead to severe …

Context.—The coronavirus disease 2019 (COVID-19) is a highly contagious respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

The COVID‐19 pandemic has become an urgent issue in every country. Based on recent
reports, the most severely ill patients present with coagulopathy, and disseminated …

December 2019 will never be forgotten in the history of medicine when an outbreak of
pneumonia of unknown etiology in Wuhan, China sooner or later prompted the World Health …

Coagulopathy correlates with severity of COVID-19 and may include increased d-dimer
concentrations (≥ 2 times above normal range), mildly prolonged prothrombin time (~ 1–3 s …